Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

197 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Ranibizumab versus laser therapy for the treatment of very low birthweight infants with retinopathy of prematurity (RAINBOW): five-year outcomes of a randomised trial.
Marlow N, Reynolds JD, Lepore D, Fielder AR, Stahl A, Hao H, Weisberger A, Lodha A, Fleck BW. Marlow N, et al. Among authors: fielder ar. EClinicalMedicine. 2024 Apr 11;71:102567. doi: 10.1016/j.eclinm.2024.102567. eCollection 2024 May. EClinicalMedicine. 2024. PMID: 38638400 Free PMC article.
UK screening and treatment of retinopathy of prematurity Updated 2022 Guidelines.
Wilkinson AR, Adams GGW, Fleck BW, Nieto-Hernandez R; Guideline Development Groups (GDG) of the Royal College of Paediatrics and Child Health (RCPCH) and the Royal College of Ophthalmologists (RCOphth). Wilkinson AR, et al. Early Hum Dev. 2023 Mar;177-178:105715. doi: 10.1016/j.earlhumdev.2023.105715. Epub 2023 Jan 25. Early Hum Dev. 2023. PMID: 36780724 Free article. No abstract available.
Retinopathy of prematurity comes full circle.
Fielder AR, Quinn GE, Shah PK, Darlow BA, Marlow N. Fielder AR, et al. Arch Dis Child Fetal Neonatal Ed. 2024 Apr 11:fetalneonatal-2024-327003. doi: 10.1136/archdischild-2024-327003. Online ahead of print. Arch Dis Child Fetal Neonatal Ed. 2024. PMID: 38604651 Review. No abstract available.
Intravitreal Aflibercept vs Laser Therapy for Retinopathy of Prematurity: Two-Year Efficacy and Safety Outcomes in the Nonrandomized Controlled Trial FIREFLEYE next.
Stahl A, Nakanishi H, Lepore D, Wu WC, Azuma N, Jacas C, Vitti R, Athanikar A, Chu K, Iveli P, Zhao F, Leal S, Schlief S, Schmelter T, Miller T, Köfüncü E, Fielder A; FIREFLEYE next Study Group. Stahl A, et al. JAMA Netw Open. 2024 Apr 1;7(4):e248383. doi: 10.1001/jamanetworkopen.2024.8383. JAMA Netw Open. 2024. PMID: 38687481 Free PMC article. Clinical Trial.
Reply.
Quinn GE, Fielder AR, Chan RVP, Chiang MF; International Committee for the Classification of Retinopathy of Prematurity. Quinn GE, et al. Among authors: fielder ar. Ophthalmology. 2022 Jun;129(6):e65-e66. doi: 10.1016/j.ophtha.2022.01.026. Epub 2022 Mar 4. Ophthalmology. 2022. PMID: 35256216 No abstract available.
Time Course of Retinopathy of Prematurity Regression and Reactivation After Treatment with Ranibizumab or Laser in the RAINBOW Trial.
Fleck BW, Reynolds JD, Zhu Q, Lepore D, Marlow N, Stahl A, Li J, Weisberger A, Fielder AR; RAINBOW Investigator Group. Fleck BW, et al. Among authors: fielder ar. Ophthalmol Retina. 2022 Jul;6(7):628-637. doi: 10.1016/j.oret.2022.02.006. Epub 2022 Feb 22. Ophthalmol Retina. 2022. PMID: 35202890 Free article. Clinical Trial.
Reply.
Chiang MF, Quinn GE, Fielder AR, Chan RVP, Fleck B; of the International Committee for the Classification of Retinopathy of Prematurity. Chiang MF, et al. Among authors: fielder ar. Ophthalmology. 2022 Mar;129(3):e36-e37. doi: 10.1016/j.ophtha.2021.10.020. Epub 2021 Nov 26. Ophthalmology. 2022. PMID: 34844763 No abstract available.
197 results